FewerJobs.
All jobs

Executive Director, US Portfolio Analytics

Revolution Medicines - Redwood City, California, United States

Posted Sep 24, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Nov 20, 2026
Salary
$265K-$331K From the posting source
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$111,944 U.S. median for this role
Projected growth (BLS Employment Projections)
+13.7% - Much faster than average

166% above the BLS role benchmark for data and ml aggregate.

Matched to SOC 15-1252 - Data and ML aggregate by role bucket.

Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.

Role

Role function
Data From the posting source
Seniority
Staff Plus From the posting source

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Executive Director, US Portfolio Analytics Redwood City, California, United States Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines' US business. This leader will be accountable for Field Analytics, Market Access Analytics, Data Strategy & Governance, Omnichannel Analytics, and Dashboards, ensuring scalable, integrated capabilities that support launch readiness, commercialization, and performance management across the portfolio. This role will serve as a strategic thought partner to US Commercial leadership and franchise Analytics & Insights leaders, translating business priorities into an integrated analytics roadmap and establishing consistent standards, methodologies, data definitions, and decision support across brands and functions. The Executive Director will operate as a player/coach-personally engaging in high-priority analyses and capability design while building, leading, and developing a high-performing

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.

Apply at revmed.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs